Synapse - Works

Results (476)

Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissues

Journal Article

Moukarzel, L. A.; Ferrando, L.; Dopeso, H.; Stylianou, A.; Basili, T.; Pareja, F.; Da Cruz Paula, A.; Zoppoli, G.; Abu-Rustum, N. R.; Reis-Filho, J. S.; more...
Gynecologic Oncology (2022)

Fulltext@MSK | Save

A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma

Journal Article

Stover, E. H.; Xiong, N.; Myers, A. P.; Tayob, N.; Engvold, V.; Polak, M.; Broaddus, R. R.; Makker, V.; Drapkin, R.; Liu, J. F.; more...
Gynecologic Oncology Reports (2022)

Fulltext@MSK | Save

Validation of a population-based data source to examine national cancer clinical trial participation

Journal Article

Green, A. K.; Tabatabai, S. M.; Bai, X.; Mishra Meza, A.; Lesny, A. M.; Aghajanian, C.; Landgren, O.; Riely, G. J.; Sabbatini, P.; Salner, A, ; more...
JAMA Network Open (2022)

Fulltext@MSK | Save

Risk-reducing bilateral salpingo-oophorectomy for ovarian cancer: A review and clinical guide for hereditary predisposition genes

Review

Liu, Y. L.; Breen, K.; Catchings, A.; Ranganathan, M.; Latham, A.; Goldfrank, D. J.; Grisham, R. N.; Long Roche, K.; Frey, M. K.; Chi, D. S.; more...
JCO Oncology Practice (2022)

Fulltext@MSK | Save

Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

Journal Article

Nguyen, B.; Fong, C.; Luthra, A.; Smith, S. A.; DiNatale, R. G.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Madupuri, R.; Kundra, R.; more...
Cell (2022)

Fulltext@MSK | Save

Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study

Journal Article

Swisher, E. M.; Aghajanian, C.; O'Malley, D. M.; Fleming, G. F.; Kaufmann, S. H.; Levine, D. A.; Birrer, M. J.; Moore, K. N.; Spirtos, N. M.; Shahin, M. S.; more...
Gynecologic Oncology (2022)

Fulltext@MSK | Save

Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer – An ancillary data analysis of the VELIA trial

Journal Article

Aghajanian, C.; Swisher, E. M.; Okamoto, A.; Steffensen, K. D.; Bookman, M. A.; Fleming, G. F.; Friedlander, M.; Moore, K. N.; Tewari, K. S.; O'Malley, D. M.; more...
Gynecologic Oncology (2022)

Fulltext@MSK | Save

Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer

Journal Article

Manning-Geist, B. L.; Gordhandas, S. B.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; O'Cearbhaill, R. E.; Zamarin, D.; Lichtman, S. M.; Sabbatini, P. J.; more...
Gynecologic Oncology (2022)

Fulltext@MSK | Save

Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer

Journal Article

Gordhandas, S. B.; Manning-Geist, B.; Henson, C.; Iyer, G.; Gardner, G. J.; Sonoda, Y.; Moore, K. N.; Aghajanian, C.; Chui, M. H.; Grisham, R. N.
Scientific Reports (2022)

Fulltext@MSK | Save

TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition

Journal Article

Chiang, S.; Vasudevaraja, V.; Serrano, J.; Stewart, C. J. R.; Oliva, E.; Momeni-Boroujeni, A.; Jungbluth, A. A.; Da Cruz Paula, A.; da Silva, E. M.; Weigelt, B.; more...
Modern Pathology (2022)

Fulltext@MSK | Save